Phase II trial of cisplatin, gemcitabine, and bevacizumab as first-line therapy for metastatic urothelial carcinoma: Hoosier oncology group GU 04-75

Noah M. Hahn, Walter M. Stadler, Robin T. Zon, David Waterhouse, Joel Picus, Sreenivasa Nattam, Cynthia S. Johnson, Susan M. Perkins, Mary Jane Waddell, Christopher J. Sweeney

Research output: Contribution to journalArticlepeer-review

173 Scopus citations

Fingerprint

Dive into the research topics of 'Phase II trial of cisplatin, gemcitabine, and bevacizumab as first-line therapy for metastatic urothelial carcinoma: Hoosier oncology group GU 04-75'. Together they form a unique fingerprint.

Medicine & Life Sciences